Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors. [electronic resource]
Producer: 20060726Description: 3092-8 p. digitalISSN:- 1078-0432
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Lactones -- administration & dosage
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Sulfones -- administration & dosage
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.